reports
Shoals Technologies Group Expands Leadership Team with Key Appointment...
Shoals Technologies Group Expands Leadership Team with Key Appointments in International Business and Investor Relations PORTLAND, Tenn., May 09, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc., a leading provider of electrical balance of systems (“EBOS”) solutions for solar, battery storage, and electric vehicle charging infrastructure, today announced the appointment of Gary Uren as Senior Vice President and General Manager (SVPGM) over International Business and Matt Tractenberg as Vice President of Finance and Investor Relations. Gary Uren is a growth-oriented senior busines...
Erasca Reports First Quarter 2024 Business Updates and Financial Resul...
Erasca Reports First Quarter 2024 Business Updates and Financial Results Median OS of 13-14 months for naporafenib plus trametinib in pooled analysis of patients with NRASm melanoma Strengthened balance sheet with private placement financing from high-quality new and existing healthcare-focused investors Pro forma cash, cash equivalents, and marketable securities of $334 million is expected to fund operations into H2 2026 SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, an...
Shoals Technologies Group, Inc. Reports Financial Results for First Qu...
Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2024 – Quarterly Revenue of $90.8 million –– Gross Margin of 40.2% –– Net Income of $4.8 million –– Adjusted EBITDA of $20.5 million –– Backlog and Awarded Orders Increased 17% Year-Over-Year to $615.2 million –– Provides Second Quarter and Full Year 2024 Outlook – PORTLAND, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system (“EBOS”) solutions for solar, battery storage, and electric vehicle chargin...
Erasca to Present at the Bank of America Health Care Conference
Erasca to Present at the Bank of America Health Care Conference SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Bank of America Health Care Conference being held at the Encore Hotel in Las Vegas, Nevada. Management will present on Wednesday, May 15, 2024 at 4:20 pm Pacific Time and will also participate in one-on-one investor meetings. A live audio webca...
- Jonathan Moreland
SPWR SUNPOWER CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
FRAF FRANKLIN FINANCIAL SERVICES CO.
ZM ZOOM VIDEO COMMUNICATIONS
MRBK INC.
RYES MERIDIAN
LUMN PATRIOT MINEFINDERS INC.
VPV LUMEN TECHNOLOGIES INC.
MEGI INVESCO PA VALUE MUNI INC TST
IZEA MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
IZEA WORLDWIDE INC
- Jonathan Moreland
FFIN FIRST FINANCIAL BANKSHARES INC
CINF CINCINNATI FINANCIAL CORPORATION
CHDN CHURCHILL DOWNS INCORPORATED
HWBK HAWTHORN BANCSHARES
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
CLF CLIFFS NATURAL RESOURCES INC.
PWOD PENNS WOODS BANCORP INC.
PCB PACIFIC CITY FINANCIAL CORP
RYES PATRIOT MINEFINDERS INC.
HQL TEKLA LIFE SCIENCES INVESTORS
BHRB BURKE & HERBERT BANK & TR/VA
NPCT NUVEEN CORE PLUS IMPACT FD
GNLX GENELUX CORP
LSXMK LIBERTY SIRIUSXM GROUP
NBBK NB BANCORP INC.
ASGI ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting Oral presentation will feature updated HERKULES-3 results for ERK1/2 inhibitor ERAS-007 in combination with encorafenib and cetuximab in BRAFm colorectal cancer Poster presentations will feature SEACRAFT-1 Phase 1 trial design for naporafenib plus trametinib in RAS Q61X mutations, and preliminary FLAGSHP-1 Phase 1 results for ERAS-601 and cetuximab in chordoma SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, develop...
Shoals Technologies Group, Inc. Announces First Quarter 2024 Earnings ...
Shoals Technologies Group, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call PORTLAND, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2024 results after market close on Tuesday, May 7, 2024, to be followed by a conference call at 5:00 p.m. (Eastern Time) on the same day. Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at . T...
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
BRT BRT APARTMENTS
FPF FIRST TRUST INTERMEDIATE DURATION PREFERRED AND INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
EGLE INC.
MPA EAGLE BULK SHIPPING
BUKS BLACKROCK MUNIYIELD PENNSYLVANIA FD
NPCT BUTLER NATIONAL CORP
ASGI NUVEEN CORE PLUS IMPACT FD
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
- Jonathan Moreland
- Jonathan Moreland
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
BRT BRT APARTMENTS
FMN FEDERATED PREMIER MUNICIPAL INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
BFZ INC.
MPA BLACKROCK CALIF MUN INCOME TRUST
AMPX BLACKROCK MUNIYIELD PENNSYLVANIA FD
BIGZ AMPRIUS TECHNOLOGIES INC
ECAT BLACKROCK INNOVATION AND GROWTH TST
NPCT BLACKROCK ESG CAP ALLOCATION TR
ELVN NUVEEN CORE PLUS IMPACT FD
BMEZ IMARA INC
ASGI BLACKROCK HEALTH SCIENCES TERM TRUST
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
- Jonathan Moreland
AXR AMREP
CWEN CLEARWAY ENERGY INC. CLASS C
SOWG SOW GOOD INC.
FSBC FIVE STAR BANCORP
BFZ BLACKROCK CALIF MUN INCOME TRUST
BIGZ BLACKROCK INNOVATION AND GROWTH TST
ECAT BLACKROCK ESG CAP ALLOCATION TR
BMEZ BLACKROCK HEALTH SCIENCES TERM TRUST
TISI TEAM INC.
- Jonathan Moreland
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
FMN FEDERATED PREMIER MUNICIPAL INCOME FUND
AXR AMREP
SMMT SUMMIT THERAPEUTICS INC
DERM JOURNEY MEDICAL CORP
LEE LEE ENTERPRISES INC
BFZ BLACKROCK CALIF MUN INCOME TRUST
MPA BLACKROCK MUNIYIELD PENNSYLVANIA FD
BIGZ BLACKROCK INNOVATION AND GROWTH TST
ECAT BLACKROCK ESG CAP ALLOCATION TR
BMEZ BLACKROCK HEALTH SCIENCES TERM TRUST
TISI TEAM INC.
Erasca Announces $45 Million Oversubscribed Private Placement Financin...
Erasca Announces $45 Million Oversubscribed Private Placement Financing Funding from new and existing investors extends anticipated cash runway into H2 2026 SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS) (“Erasca”), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors to sell 21,844,660 shares of its common stock i...
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates...
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results Gained global registrational clarity for naporafenib and achieved key clinical milestones for naporafenib, ERAS-007, and ERAS-801 Multiple data readouts expected in 2024 for naporafenib (SEACRAFT-1), ERAS-007 (HERKULES-3), and ERAS-801 (THUNDERBBOLT-1) and planned initiation of pivotal SEACRAFT-2 trial Robust balance sheet with cash, cash equivalents, and marketable securities of $322 million as of December 31, 2023 Erasca to host R&D update conference call and webcast Thursday, March 28, 2...
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.